Abstract
BackgroundCancer vaccine immunotherapy facilitates the immune system’s recognition of tumor-associated antigens (TAAs), and the biomolecular design of these vaccines using nanoparticles is one important approach to elicit strong anti-tumor responses....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
